Today, February 6, 2018, the prospects for coherent U.S. regulation on cryptocurrencies became a little more clear, as were the impasses that were frustrating...
The written testimony from Jay Clayton, chairman of the United States Securities and Exchange Commission (SEC), was released on February 5, 2018. It comes...
In a story that is getting all too familiar recently, the Securities Exchange Commission (SEC) halted trading on yet another blockchain-related company stock, UBI...
Five weeks ago, the U.S. Commodity Futures Trading Commission (CFTC) announced three exchanges had self-certified Bitcoin derivatives products. Following the subsequent backlash from the...
Yesterday, January 4, 2018, the three prominent figures of the U.S. Securities and Exchange Commission (SEC) endorsed the concerns raised in the North American Securities...
On December 11, the U.S. Securities and Exchange Commision (SEC) issued a cease-and-desist to California-based Munchee Inc. to stop their ICO and return the...
A startling trend has recently emerged in the cryptocurrency industry. Since July 2017, the U.S. Securities and Exchange Commission (SEC) has regularly begun asserting...
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for...
